Scott Hauswirth
Corneal and Contact Management · Bloomington, MNNPI 1417942665
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (43.7%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 18.4%. Reporting peaked in 2019 at $34,795 and has fallen 99.4% since, to $199 in 2024. Among corneal and contact management clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 170 payments — averaging $431.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kala Pharmaceuticals, Inc.$13K
- Dompe US, Inc.$13K
- Shire North American Group Inc$12K
- Sight Sciences, Inc.$9K
- Sun Pharmaceutical Industries Inc.$8K
- Oyster Point Pharma, Inc.$6K
- plus $12K from 11 others
Across 4 payments — averaging $3676.04 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Oyster Point Pharma, Inc.$15K
What the payments were for
- Consulting fees$32,05544%
- Speaking & faculty fees$30,37041%
- Travel & lodging$4,3416%
- Food & beverage$6,5129%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kala Pharmaceuticals, Inc. | 23 | $13,468 |
| Dompe US, Inc. | 24 | $12,900 |
| Shire North American Group Inc | 16 | $12,216 |
| Sight Sciences, Inc. | 28 | $9,000 |
| Sun Pharmaceutical Industries Inc. | 14 | $7,923 |
| Oyster Point Pharma, Inc. | 18 | $5,621 |
| AbbVie(2 entities) | 14 | $2,480 |
| Biotissue Holdings Inc. | 2 | $1,750 |
| Quidel Corporation | 7 | $1,476 |
| Amgen | 4 | $1,025 |
| Glaukos Corporation | 2 | $1,025 |
| Eyevance Pharmaceuticals LLC | 2 | $1,021 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $1,000 |
| Alcon | 4 | $928 |
| Eyepoint US, Inc. | 2 | $854 |
| Ocular Therapeutix, Inc. | 7 | $549 |
| Novartis | 2 | $42 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EYSUVIS$12,137
- XIIDRA$11,995
- Oxervate$9,757
- CEQUA$7,546
- TearCare$7,529
- TYRVAYA$5,393
- Prokera$1,750
- AmnioGraft$1,750
- AmnioGuard$1,750
- DEXTENZA$1,448
- VUITY$1,312
- Eye Health$1,200
- Flarex$1,000
- Tecnis Symfony IOL$1,000
- DAILIES$928
- TEPEZZA$876
- TearCare SmartLid$863
- TEARCARE(TM) (2.2) SYSTEM KIT$863
- DEXYCU$800
- AIR OPTIX$648
How this compares
$73,278 in reported general payments places this provider in the 95th percentile of 30 corneal and contact management providers in Minnesota.
See all corneal and contact management providers in Minnesota →
Other corneal and contact management in Bloomington
- Mark BuboltzBloomington$6K
- Johnna HobbsBloomington$2K
- Mona FahmyBloomington$623
- Tara BarthBloomington$586
- Sonja Iverson-HillBloomington$375
- Benjamin FogalBloomington$186
- Gina DoedenBloomington$132
- Noumia Cloutier-GillBloomington$36
- Ahmad FahmyMinneapolis$222K
- Tina McCartyFridley$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.